๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of cerebral white matter changes on clinical response to cholinesterase inhibitors in dementia

โœ Scribed by Devine, M.E.; Saez Fonseca, J.A.; Walker, R.W.; Sikdar, T.; Stevens, T.; Walker, Z.

Book ID
122962618
Publisher
Elsevier Science
Year
2007
Tongue
French
Weight
43 KB
Volume
22
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hypertension, white matter change and re
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
โœ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype

Cerebral white matter changes and rate o
Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study
โœ M. E. Devine; J. A. S. Fonseca; R. W. H. Walker; T. Sikdar; T. Stevens; Z. Walke ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 117 KB

## Abstract ## Background Cerebral white matter changes (WMC) represent cerebrovascular disease (CVD) and are common in dementia. Cholinesterase inhibitors (ChEIs) are effective in Alzheimer's Disease (AD) with or without CVD, and in Dementia with Lewy Bodies (DLB). Predictors of treatment respons